Top compounds associated with response to PLCH1


Feature Type Standardized
Nominal ANOVA
mRNA Teniposide CTRPv2 pan-cancer AAC 0.089 0.02
mRNA PDMP CTRPv2 pan-cancer AAC 0.085 0.02
mRNA Vandetanib CCLE pan-cancer AAC 0.11 0.02
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.081 0.02
mRNA CD-1530 CTRPv2 pan-cancer AAC -0.086 0.03
mRNA Bosutinib GDSC1000 pan-cancer AAC 0.076 0.03
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.03
mRNA TG-101348 GDSC1000 pan-cancer AAC 0.065 0.03
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.03
Download CSV